This Company Is More Investable Than It’s Ever Been And Is Rated A “Buy”

Bristol-Myers Squibb Co. is a high-quality biopharmaceutical company with one of the best-selling products in its entire industry. Huge long-term demographic tailwinds blow its way, further bolstering their prospects.